Difference between clinical and pathologic renal tumor size, correlation with survival, and implications for patient counseling regarding nephron-sparing surgery
Brookman-May S, Johannsen M, May M, Hoschke B, Gunschera J, Wieland WF, Burger M
AJR Am J Roentgenol. 2011 Nov;197(5):1137-45
Collecting system invasion and Fuhrman grade but not tumor size facilitate prognostic stratification of patients with pT2 renal cell carcinoma
Brookman-May S, May M, Zigeuner R, Shariat SF, Scherr DS, Chromecki T, Moch H, Wild PJ, Mohamad-Al-Ali B, Cindolo L, Wieland WF, Schips L, De Cobelli O, Rocco B, Santoro L, De Nunzio C, Tubaro A, Coman I, Feciche B, Truss M, Dalpiaz O, Hohenfellner M, Gilfrich C, Wirth MP, Burger M, Pahernik S; CORONA Project (Collaborative Research on Renal Neoplasms Association).
J Urol. 2011 Dec;186(6):2175-81
Todd M. Morgan, Dominic Tang, Kelly L. Stratton, et al. Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma. Eur Urol 2011;59:923-8. Umberto Capitanio, Francesco Montorsi. Does preoperative nutritional status affect survival in renal cell carcinoma? The debate continues. Eur Urol 2011;59:929-30
Eur Urol. 2011 Nov;60(5):e45-6; author reply e47 Brookman-May S, Burger M, Wieland WF, May M
Vaccination therapy in renal cell carcinoma: current position and future options in metastatic and localized disease
Brookman-May S, Burger M, Wieland WF, Rössler W, May M, Denzinger S
Expert Rev Vaccines. 2011 Jun;10(6):837-52. Review
Impact of body mass index and weight loss on cancer-specific and overall survival in patients with surgically resected renal cell carcinoma
Brookman-May S, Kendel F, Hoschke B, Wieland WF, Burger M, Rössler W, May M
Scand J Urol Nephrol. 2011 Feb;45(1):5-14
Transrectal high-intensity focused ultrasound for local treatment of prostate cancer: current role
Chaussy CG, Thüroff S
Arch Esp Urol. 2011 Jul;64(6):493-506. Review
Robotic high-intensity focused ultrasound for prostate cancer: what have we learned in 15 years of clinical use?
Chaussy CG, Thüroff SF
Curr Urol Rep. 2011 Jun;12(3):180-7. Review
Shock wave technology and application: an update
Rassweiler JJ, Knoll T, Köhrmann KU, McAteer JA, Lingeman JE, Cleveland RO, Bailey MR, Chaussy CG
Eur Urol. 2011 May;59(5):784-96. Review
Substaging by estimating the size of invasive tumour can improve risk stratification in pT1 urothelial bladder cancer-evaluation of a large hospital-based single-centre series
Denzinger S, Bertz S, Otto W, Wieland WF, Stoehr R, Hofstaedter F, Hartmann A
Histopathology. 2011 Oct;59(4):722-32
Water-jet-aided transurethral dissection of urothelial carcinoma: a prospective clinical study
Fritsche HM, Otto W, Eder F, Hofstädter F, Denzinger S, Chaussy CG, Stief C, Wieland WF, Burger M
J Endourol. 2011 Oct;25(10):1599-603
Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladder
May M, Bastian PJ, Burger M, Bolenz C, Trojan L, Herrmann E, Wülfing C, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Otto W, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Wieland WF, Fritsche HM
BJU Int. 2011 Oct;108(8 Pt 2):E278-83
Pathological upstaging detected in radical cystectomy procedures is associated with a significantly worse tumour-specific survival rate for patients with clinical T1 urothelial carcinoma of the urinary bladder
May M, Bastian PJ, Brookman-May S, Burger M, Bolenz C, Trojan L, Michel MS, Herrmann E, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Gunia S, Fritsche HM
Scand J Urol Nephrol. 2011 Sep;45(4):251-7
Correlation of prostate-specific antigen nadir and biochemical failure after high-intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria - analysis from the @-Registry
Ganzer R, Robertson CN, Ward JF, Brown SC, Conti GN, Murat FJ, Pasticier G, Rebillard X, Thuroff S, Wieland WF, Blana A
BJU Int. 2011 Oct;108(8 Pt 2):E196-201
Anatomical description of the periprostatic nerves in the male rhesus monkey (Macaca mulatta)
Ganzer R, Neuhaus J, Gratzke C, Blana A, Wieland WF, Stolzenburg JU
World J Urol. 2011 Jun;29(3):375-80
The enlightenment of bladder cancer treatment: origin and progress of photodynamic diagnosis
Otto W, Burger M, Fritsche HM, Rössler W, Wieland WF, Denzinger S
Future Oncol. 2011 Sep;7(9):1057-66. Review
Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients
Otto W, Shariat SF, Fritsche HM, Gupta A, Matsumoto K, Kassouf W, Martignoni G, Walton TJ, Tritschler S, Baba S, Bastian PJ, Martínez-Salamanca JI, Seitz C, Pycha A, Burger M, Karakiewicz PI, Ficarra V, Novara G
World J Urol. 2011 Aug;29(4):487-94
Serine threonine kinase 15 amplification in normal urothelium of cystectomy specimens is no prognostic factor in urothelial carcinoma of the bladder
Otto W, Fritsche HM, Wild PJ, Wieland WF, Hartmann A, Burger M, Hofstädter F, Denzinger S
Pathol Res Pract. 2011 Mar 15;207(3):161-3
The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer
Otto W, Denzinger S, Fritsche HM, Burger M, Wieland WF, Hofstädter F, Hartmann A, Bertz S
BJU Int. 2011 Feb;107(3):404-8
Validation of pre-cystectomy nomograms for the prediction of locally advanced urothelial bladder cancer in a multicentre study: are we able to adequately predict locally advanced tumour stages before surgery?
May M, Burger M, Brookman-May S, Otto W, Peter J, Rud O, Fritsche HM, Bolenz C, Trojan L, Herrmann E, Michel MS, Wülfing C, Moritz R, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Bretschneider-Ehrenberg P, Müller O, Zacharias M, Gunia S, Bastian PJ
Urologe A. 2011 Jun;50(6):706-13. German
Influence of older age on survival after radical cystectomy due to urothelial carcinoma of the bladder: survival analysis of a German multi-centre study after curative treatment of urothelial carcinoma of the bladder
May M, Fritsche HM, Gilfrich C, Brookman-May S, Burger M, Otto W, Bolenz C, Trojan L, Herrmann E, Michel MS, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Müller O, Bretschneider-Ehrenberg P, Zacharias M, Gunia S, Bastian PJ
Urologe A. 2011 Jul;50(7):821-9. German
Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma
Shariat SF, Favaretto RL, Gupta A, Fritsche HM, Matsumoto K, Kassouf W, Walton TJ, Tritschler S, Baba S, Matsushita K, Bastian PJ, Martínez-Salamanca JI, Seitz C, Pycha A, Otto W, Karakiewicz PI, Ficarra V, Novara G
World J Urol. 2011 Aug;29(4):481-6
Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy
May M, Herrmann E, Bolenz C, Tiemann A, Brookman-May S, Fritsche HM, Burger M, Buchner A, Gratzke C, Wülfing C, Trojan L, Ellinger J, Tilki D, Gilfrich C, Höfner T, Roigas J, Zacharias M, Gunia S, Wieland WF, Hohenfellner M, Michel MS, Haferkamp A, Müller SC, Stief CG, Bastian PJ
Eur Urol. 2011 May;59(5):712-8
Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy
May M, Herrmann E, Bolenz C, Brookman-May S, Tiemann A, Moritz R, Fritsche HM, Burger M, Trojan L, Michel MS, Wülfing C, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Bastian PJ
Ann Surg Oncol. 2011 Jul;18(7):2018-25
DNA adducts of ortho-toluidine in human bladder
Böhm F, Schmid D, Denzinger S, Wieland WF, Richter E
Biomarkers. 2011 Mar;16(2):120-8
Medical and Economic Aspects of Extracorporeal Shock Wave Lithotripsy
Knoll T, Fritsche HM, Rassweiler J
Aktuelle Urol. 2011 Nov;42(6):363-7
Concomitant carcinoma in situ in cystectomy specimens is not associated with clinical outcomes after surgery
Nuhn P, Bastian PJ, Novara G, Svatek RS, Karakiewicz PI, Skinner E, Fradet Y, Izawa JI, Kassouf W, Montorsi F, Müller SC, Fritsche HM, Sonpavde G, Tilki D, Isbarn H, Ficarra V, Dinney CP, Shariat SF
Urol Int. 2011;87(1):42-8
No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study
Burger M, Shariat SF, Fritsche HM, Martinez-Salamanca JI, Matsumoto K, Chromecki TF, Ficarra V, Kassouf W, Seitz C, Pycha A, Tritschler S, Walton TJ, Novara G
World J Urol. 2011 Aug;29(4):465-72
Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study
Matsumoto K, Novara G, Gupta A, Margulis V, Walton TJ, Roscigno M, Ng C, Kikuchi E, Zigeuner R, Kassouf W, Fritsche HM, Ficarra V, Martignoni G, Tritschler S, Rodriguez JC, Seitz C, Weizer A, Remzi M, Raman JD, Bolenz C, Bensalah K, Koppie TM, Karakiewicz PI, Wood CG, Montorsi F, Iwamura M, Shariat SF
BJU Int. 2011 Oct;108(8 Pt 2):E304-9
Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy
Chromecki TF, Ehdaie B, Novara G, Pummer K, Zigeuner R, Seitz C, Pycha A, Lee RK, Cha EK, Karakiewicz PI, Ng C, Raman JD, Chun FK, Fritsche HM, Matsumoto K, Kassouf W, Walton TJ, Bastian PJ, Martínez-Salamanca JI, Scherr DS, Shariat SF
World J Urol. 2011 Aug;29(4):473-80
Prognostic risk stratification of pathological stage T3N0 bladder cancer after radical cystectomy
Sonpavde G, Khan MM, Svatek RS, Lee R, Novara G, Tilki D, Lerner SP, Amiel GE, Skinner E, Karakiewicz PI, Bastian PJ, Kassouf W, Fritsche HM, Izawa JI, Scherr DS, Ficarra V, Dinney CP, Lotan Y, Fradet Y, Shariat SF
J Urol. 2011 Apr;185(4):1216-21
Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort
Svatek RS, Shariat SF, Novara G, Skinner EC, Fradet Y, Bastian PJ, Kamat AM, Kassouf W, Karakiewicz PI, Fritsche HM, Izawa JI, Tilki D, Ficarra V, Volkmer BG, Isbarn H, Dinney CP
BJU Int. 2011 Mar;107(6):898-904
Disease-free survival at 2 or 3 years correlates with 5-year overall survival of patients undergoing radical cystectomy for muscle invasive bladder cancer
Sonpavde G, Khan MM, Lerner SP, Svatek RS, Novara G, Karakiewicz PI, Skinner E, Tilki D, Kassouf W, Fradet Y, Dinney CP, Fritsche HM, Izawa JI, Bastian PJ, Ficarra V, Schoenberg M, Sagalowsky AI, Lotan Y, Shariat SF
J Urol. 2011 Feb;185(2):456-61
Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy
Sonpavde G, Khan MM, Svatek RS, Lee R, Novara G, Tilki D, Lerner SP, Amiel GE, Skinner E, Karakiewicz PI, Bastian PJ, Kassouf W, Fritsche HM, Izawa JI, Ficarra V, Dinney CP, Lotan Y, Fradet Y, Shariat SF
BJU Int. 2011 Sep;108(5):687-92
Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort
Walton TJ, Novara G, Matsumoto K, Kassouf W, Fritsche HM, Artibani W, Bastian PJ, Martínez-Salamanca JI, Seitz C, Thomas SA, Ficarra V, Burger M, Tritschler S, Karakiewicz PI, Shariat SF
BJU Int. 2011 Aug;108(3):406-12
The plasmacytoid carcinoma of the bladder-rare variant of aggressive urothelial carcinoma
Keck B, Stoehr R, Wach S, Rogler A, Hofstaedter F, Lehmann J, Montironi R, Sibonye M, Fritsche HM, Lopez-Beltran A, Epstein JI, Wullich B, Hartmann A
Int J Cancer. 2011 Jul 15;129(2):346-54
Kontakt
Terminvereinbarung und
Befundanforderungen:
E-Mail uro-ambulanz(at)csj.de
Telefon 0941 782-3511
Fax 0941 782-3545
Sekretariat:
E-Mail urologie(at)csj.de
Telefon 0941 782-3510
Fax 0941 782-3515
